高影响力期刊的编辑每周收到数百篇投稿。投稿信通常是他们阅读的第一份文字。一封糟糕的投稿信不一定直接导致拒稿，但会在编辑打开论文正文之前，影响他们对这篇稿件和研究团队的第一印象。
很多研究者把投稿信当作最后一步草草完成，花了几周反复修改论文，却在投稿前花十分钟写完这封信。以下是最常见的五类错误，附具体示例和修改建议。
1. 写成了摘要复述，而不是”为什么选这本期刊”
大多数投稿信的开头都是摘要的压缩版：研究做了什么、发现了什么、得出了什么结论。这是一次错失的机会。编辑已经有摘要了。他们需要从投稿信里得到的，是另一个问题的答案：这篇稿件为什么属于这本期刊？
典型原文：
We conducted a prospective cohort study of 312 patients with type 2 diabetes. HbA1c levels were measured at baseline and 12 months after initiating SGLT2 inhibitor therapy. Our results show that HbA1c was significantly reduced at 12 months. We conclude that SGLT2 inhibitors are effective in this patient population.
这段话可以直接换成摘要。它告诉编辑做了什么，但没有说明为什么这项研究适合这本期刊的定位和读者群。
修改思路： 以研究所针对的临床或科学问题开头，简洁说明本研究的贡献，然后将这一贡献与期刊的方向和读者群明确联系起来。
修改版：
Glycemic management in patients aged 65 to 80 with type 2 diabetes remains poorly defined. This population is systematically underrepresented in SGLT2 inhibitor trials, and current guidelines offer limited dosing guidance for this age group. This prospective cohort study of 312 patients provides evidence that SGLT2 inhibitor therapy reduces HbA1c by a clinically meaningful margin (mean reduction 1.2%, 95% CI 0.9–1.5%) in this underserved group. We believe these findings address a gap directly relevant to the readership of [Journal Name].
2. 对期刊匹配性的论证流于套话
投稿信中频繁出现这样一句话：
This topic is of broad interest to researchers in the field and will be relevant to the readership of your journal.
这句话什么也没说。编辑一眼就能认出这是填充语句，说明作者没有认真研究这本期刊近期发表的内容，也没有考虑其具体的读者群。向任何期刊投稿的任何作者都可以原封不动地写下这句话。
修改思路： 引用两三篇该期刊近期发表的相关文章，说明本稿件如何延伸或补充那条研究线索。
示例：
[Journal Name] has published several recent studies on metabolic outcomes in high-risk diabetic populations, including [Author A] et al. (2024) and [Author B] et al. (2025). Our study extends this line of work by focusing specifically on patients aged 65 to 80, a group largely absent from existing trial data.
准备这些内容只需十分钟，却能让投稿信的说服力大幅提升。
3. 夸大研究的新颖性
投稿信往往是作者对研究新颖性发出最强声音的地方。这些主张清晰、集中，而且很容易对照已发表文献进行核查。“史上首篇”、“突破性进展”、“颠覆范式”等表述频繁出现，带来一个可预见的问题：一旦这类声明不准确或被夸大，编辑在翻开论文正文之前对整篇稿件的信心就已经打折扣了。
典型原文：
This is the first study ever to investigate SGLT2 inhibitor therapy in elderly diabetic patients and represents a groundbreaking advance in the management of this condition.
问题所在：
- “史上首篇”几乎从不准确，而且很容易被核查
- “突破性”是属于科学共同体的判断，不是作者自己的评价
- 绝对化的新颖性声明引发的是质疑，而不是认可
修改版：
To our knowledge, this is among the first prospective studies to focus specifically on patients aged 65 to 80, a population typically excluded from SGLT2 inhibitor trials due to renal function entry criteria. The findings may help inform prescribing decisions in a patient group for whom current evidence is limited.
有限定语的表述（“据我们所知”、“首批之一”）并不更弱，而是更精确、更可信。
4. 遗漏必要的声明事项
大多数期刊要求投稿信中包含明确的声明：稿件未同时投递至其他期刊、所有作者已审阅并批准投稿，以及在某些情况下还需要利益冲突声明和伦理审批说明。这些要求在期刊的投稿指南中均有明文规定。
常见问题有两种：要么这些声明完全缺失，要么声明存在，但夹杂在科学论述段落中，既打乱了结构，又容易被编辑忽略。
典型原文（声明埋入正文）：
We believe this manuscript will be of interest to your readers. No funding was received for this study and none of the authors has a conflict of interest. All authors have reviewed and approved the manuscript, which has not been submitted elsewhere, and the study was approved by the institutional ethics committee. We look forward to the possibility of publication in [Journal Name].
科学论述和行政声明混在同一段落里，两者都变得难以阅读，声明也容易被忽略。
推荐做法： 将所有声明放在明确标注的独立末尾段落，与科学论述分开。
示例结构：
[科学论述段落]
Declarations
- Exclusive submission: This manuscript is not under review at any other journal.
- Author approval: All authors have reviewed and approved the final manuscript.
- Conflicts of interest: None to declare.
- Ethics: The study was approved by [Institution] Ethics Committee (reference number XXXX).
编辑可以一目了然地确认合规情况，无需在正文中逐字查找。
5. 结尾过于被动或越权要求
很多投稿信的最后一句是：
We hope you will consider our manuscript for publication in your journal.
语法上没有问题，但没有实质内容。所有主动权都交给了编辑，传递出作者对自身工作价值不确定的信号。
反方向的问题同样存在：
We respectfully request that reviewers with expertise specifically in SGLT2 inhibitor pharmacology be assigned, and that reviewers from the following research groups be excluded: [list].
要求排除特定审稿人，只适用于有明文记录利益冲突的有限情形，且需要明确说明理由。一份泛泛的排除名单会给人留下试图掌控审稿流程的印象，效果适得其反。
更有力的结尾：
We believe this manuscript is well suited for [Journal Name] and would welcome the opportunity for peer review. We are happy to provide any additional information the editorial team may require.
直接、自信，下一步由编辑部主导。
提交前的自查清单
- 开头是否说明了这篇稿件为什么属于这本期刊，而不只是说研究发现了什么？
- 新颖性声明是否有限定语（“据我们所知”、“首批之一”），而非绝对化表述？
- 所有必要声明是否完整，并与科学论述分开？
- 结尾是否明确表明希望进入同行评审？
投稿信本身很少决定一篇好论文能否被接受。但一封糟糕的投稿信，可能让一篇好论文遭到桌面拒稿，或者让编辑在发出审稿邀请时附上一条带有保留意见的说明。目标不是过度推销研究，而是让编辑的决策尽可能顺畅。
ScholarMemory 为投稿国际期刊的研究者提供专业的学术稿件润色服务。如需在投稿前对投稿信或论文进行审阅，欢迎联系 contact@scholarmemory.com。